Israel cấp phép thuốc Molnupiravir của Merck, cho phép tiêm liều 4

Bộ Y tế Israel ngày 2/1 thông báo đã cấp phép sử dụng thuốc điều trị COVID-19 do tập đoàn dược phẩm đa quốc gia Merck của Mỹ sản xuất, sau quyết định tương tự đối với thuốc Paxlovid của Pfizer.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Italy báo động: 77% thanh thiếu niên nghiện điện thoại

Italy báo động: 77% thanh thiếu niên nghiện điện thoại

Thế giới
(Baothanhhoa.vn) - Giới chức Italy cảnh báo tình trạng nghiện thiết bị số trong thanh thiếu niên đang gia tăng đáng lo ngại, khi 77% người trẻ thừa nhận phụ thuộc vào điện thoại, buộc nước này phải cân nhắc các biện pháp hạn chế sử dụng mạng xã hội theo độ tuổi.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh